This newslink doesn't exist or it was removed.
Go to Homempage.
Portland Press Herald USA World June 06, 2023
This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. AP Photo/Seth Wenig, File Merck is suing the U.S. over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies — a reform aimed at cutting costs... + más
Merck Tops Quarterly Profit Estimates but Sees Weaker 2023 Revenue on Lagevrio Sales Drop | MarketWatch
European committee: Regulators should deny Merck's Lagevrio | Associated Press
Los Angeles Times USA Business June 15, 2023
No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees. By that standard, the federal lawsuit filed June 6 by the big drug manufacturer Merck falls... + más
Healthy Mayfield 'rolling with the punches' as QB2 | ESPN
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
MarketWatch USA Business February 02, 2023
The company is expecting revenue to drop in 2023 amid a decline in sales of Lagevrio, its Covid-19 antiviral, and on Thursday set earnings guidance that was well below Wall Street expectations. Still, Merck Chief Financial Officer Caroline Litchfield said that the company’s... + más
Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10
Merck, Moderna detail potential skin cancer vaccine progress | ABC News
The Boston Globe USA Business June 06, 2023
The pharmaceutical company Merck on Tuesday sued the government over a federal law that empowers Medicare for the first time to negotiate prices directly with drug makers.Merck’s lawsuit, filed in federal court in Washington, is the drug industry’s most significant move so... + más
Merck sues U.S., calling Biden move to cut drug prices ‘extortion’ | Portland Press Herald
Associated Press USA Health February 24, 2023
A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators.A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the... + más
Moderna, Merck announce progress in vaccine against skin cancer to significantly boost survival rate | ABC7
About iurex | Privacy Policy | Disclaimer |